Form 8-K - Current report:
SEC Accession No. 0001493152-24-050443
Filing Date
2024-12-17
Accepted
2024-12-17 17:15:19
Documents
17
Period of Report
2024-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52703
2 ex10-1.htm EX-10.1 170461
3 ex99-1.htm EX-99.1 13914
4 ex10-1_001.jpg GRAPHIC 192720
  Complete submission text file 0001493152-24-050443.txt   769767

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cdt-20241212.xsd EX-101.SCH 3883
6 XBRL DEFINITION FILE cdt-20241212_def.xml EX-101.DEF 30185
7 XBRL LABEL FILE cdt-20241212_lab.xml EX-101.LAB 37007
8 XBRL PRESENTATION FILE cdt-20241212_pre.xml EX-101.PRE 27208
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6160
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 241556708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)